Actively Recruiting
Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC)
Led by Centre Henri Becquerel · Updated on 2025-12-30
192
Participants Needed
2
Research Sites
241 weeks
Total Duration
On this page
Sponsors
C
Centre Henri Becquerel
Lead Sponsor
R
Resilience
Collaborating Sponsor
AI-Summary
What this Trial Is About
The use of digital strategies to systematically monitor patients' symptoms in clinical settings allows problems to be detected at an early stage before they worsen or lead to complications. In this study, the hypothesis is that the proportion of patients with a weight loss of at least 5% between before radiotherapy/radiochemotherapy and 3 months after treatment would be lower with optimised care thanks to remote monitoring using a medical telemonitoring solution in oncology.
CONDITIONS
Official Title
Impact of Patient-Reported Outcomes for Symptom Monitoring in Patients Followed for Head and Neck Squamous Cell Carcinoma (HNSCC)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient aged over 18 and under 75 years with WHO score less than 2
- Treated for localized head and neck squamous cell carcinoma with curative intent
- Receiving radiotherapy or chemoradiotherapy exclusively or as adjuvant treatment
- Signed the informed consent form
- Affiliated with or beneficiary of a social protection scheme
- Access to a smartphone or the internet
You will not qualify if you...
- History of other cancer less than 2 years ago or progressive disease
- History of ear, nose, and throat radiotherapy
- Pregnant or breastfeeding women
- Protected adults under guardianship, curatorship, or judicial protection
- Participation in another therapeutic study
- Inability to understand the study or comply with trial requirements (language, psychological, geographical issues)
- Blindness preventing use of the telemonitoring solution
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Centre Henri Becquerel
Rouen, France
Actively Recruiting
2
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, France
Not Yet Recruiting
Research Team
S
Sebastien Thureau, MD,PhD
CONTACT
D
Doriane Richard, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here